TechCrunch

OCTOBER 28, 2022

The biotech didn’t specify what roles and departments got trimmed. The Washington- and Lagos-based genomics startup has been considered the showpiece of Africa’s fledging biotech space since it got into Y Combinator in 2019. Yet, 2022 will be a year to forget for the biotech startup.

Biotech 229

Biotech Part-Time VPE Fractional VPE Pharmaceuticals 229

TechCrunch

MARCH 12, 2023

The new capital will allow Medigo to expand its remote doctor consultations, medicine delivery services and home testing services, including blood tests, urine tests and pregnancy tests. Medigo’s app connects users to nearby licenses pharmacies and delivers medicine within 20 minutes.

Biotech 240

Biotech Healthcare Software Engineering Testing 240

TechCrunch

JUNE 6, 2022

This presents an opportunity for Insilico Medicine to emerge as a winner during the biotech spring.” ” The “prototype” lab will be located in Suzhou, an affluent eastern Chinese city adjoining Shanghai with favorable government policies for attracting biotech and autonomous driving startups.

Biotech 211

Biotech Artificial Intelligence Artificial Inteligence Pharmaceuticals 211

TechCrunch

OCTOBER 27, 2021

This will get us to the point where we can deliver the samples that food companies need for testing.”. “The scaling challenge is going to be a big one, and we are seeking partnerships or building the facilities ourselves to use the fermentation at industrial scales. The enormous challenges and abundant opportunities in climate tech.

Biotech 206

Biotech Sustainability Industry Marketing 206

Crunchbase News

JANUARY 19, 2024

Just one startup saw a big raise in the nine figures, and a handful saw $75 million — including a trio of biotech firms. tied) Cleveland Diagnostics , $75M, biotech: There have not been a lot of big raises so far this year, but the few we have seen are usually related to biotech. The round valued the company at $1.75

Biotech 97

Biotech Pharmaceuticals Fintech Testing 97

TechCrunch

SEPTEMBER 13, 2022

French biotech company WhiteLab Genomics has raised $10 million in funding for an AI platform designed to aid the discovery and development of genomic therapies. “We provide customers with exhaustive predictive models combining genetics and computational biology in order to design and select the top candidates to be tested in the lab.”

Biotech 258

Biotech Development Pharmaceuticals Machine Learning 258

TechCrunch

AUGUST 3, 2021

In 2020, 71 biotech companies went public. On July 30 alone, eight biotech companies were expected to begin trading, including Rani Therapeutics. . The product furthest along in the research cycle is the pill developed to administer octreotide (called RT-101), which was tested in a phase I clinical trial on 62 participants.

Biotech 245

Biotech Study .Net Systems Review 245

Crunchbase News

APRIL 5, 2024

Biotech took center stage, notching three of the top four rounds. Obsidian Therapeutics , $161M, biotech: It was another big week for biotech startups raising huge sums of cash. Alterome Therapeutics , $132M, biotech: Oncology biotech Alterome Therapeutics raised a $132 million Series B led by Goldman Sachs Alternatives.

Biotech 85

Biotech Energy Software Review Systems Review 85

TechCrunch

MAY 26, 2021

Where it has hit a wall in the past is not on the digital side, where any number of likely molecules or processes can be generated, but on the next step, when those notions need to be tested in vitro. So a new crop of biotech companies have worked to integrate these aspects.

Engineering 248

Engineering Biotech Chemicals Artificial Inteligence 248

Crunchbase News

FEBRUARY 16, 2024

Not exactly sure what was in the water this week, but AI and biotech led the way as happens often. Freenome , $254M, biotech: This is just the first of many big biotech raises this week. Blood-test developer Freenome raised a $254 million round led by drugmaker Roche. billion valuation.

Lambda 88

Lambda Biotech Artificial Intelligence Artificial Inteligence 88

TechCrunch

JANUARY 25, 2021

Sano Genetics says part of the new capital will be to fund free at-home DNA testing kits for 3,000 people affected by Long Covid. In particular for research involving genetics and precision therapies, it is doubly challenging to find the ‘right’ patients because genetic testing is not routine in the healthcare system”.

Research 215

Research Biotech Study Testing 215

TechCrunch

JULY 27, 2022

Biotech company Senzo just raised a $2 million round at a $20 million pre-money valuation to further extend options for lateral flow diagnostics. “Lateral flow,” in this case, is the same type of testing you’ve seen from at-home pregnancy or COVID-19 tests.

Biotech 188

Biotech Testing Coaching Study 188

TechCrunch

AUGUST 18, 2023

Using less of it for faster testing is the great white whale. Clean tech – Tied in with the biotech trend, we’re seeing a continued surge in input/output companies that process waste to produce byproducts like energy and potable water. The robotics, AI and biotech sectors all play a part here. It’s a big new data rush.

Biotech 221

Biotech Technical Review Fintech Trends 221

TechCrunch

NOVEMBER 16, 2022

. “We’re the generative brother of that: You pick the properties you want to engineer, and the model will generate sequences you can test in your laboratory.” So Cradle originated much of its own dataset in a wet lab, testing protein after protein and seeing what changes in their sequences seemed to lead to which effects.

Generative AI 206

Generative AI Artificial Inteligence Biotech Machine Learning 206

TechCrunch

AUGUST 18, 2022

Health span versus life span, longevity for pets versus humans, biotech versus wellness, seniors versus young people, dependency versus autonomy, prevention versus treatment, analytics, education, infrastructure … Almost like how fintech was not just about creating credit card startups, we will see longevity APIs, back ends and many others.

Biotech 227

Biotech Survey Fintech Education 227

TechCrunch

DECEMBER 15, 2021

” Mimi has one of the most popular at-home hearing testing apps, where around 50,000 people per month test their hearing. We also have developed tests on a TV for Philips, so you just sit on your couch and do the test on your TV.” ”

Biotech 223

Biotech Testing Technology Company 223

TechCrunch

FEBRUARY 3, 2022

For example: Imagine you’ve just had a telehealth visit, and your healthcare provider thinks it might be time for a blood test. At the moment, the company collects samples and works with Labcorp, Quest Diagnostics and Sonora Quest to process those tests. there are about 14 billion lab tests ordered every year, per the CDC.

Testing 226

Testing Healthcare Network Virtualization 226

TechCrunch

AUGUST 2, 2021

“We added fermentation/biotech technologies to enhance taste and texture,” wrote CEO and co-founder Christoph Jenny in an email to TechCrunch. Right now the big cuts are leaving the lab and entering consumer testing for taste tuning and eventually scaling. Over time the process has improved as well.

Biotech 255

Biotech Technical Review Travel Course 255

TechCrunch

JULY 14, 2021

The company’s printers and software can print more than just swabs, but the first product the company has focused on since 2020 is the InstaSwab — a 3D-printed swab used in COVID-19 tests. . While the pandemic is still a global disaster, the vaccines have changed the game when it comes to testing. Image: OPT Industries.

3D 224

3D Industry Testing Software Review 224

TechCrunch

MARCH 23, 2021

Redbird , a Ghanaian healthtech startup that allows easy access to convenient testing and ensures that doctors and patients can view the details of those test results at any time, announced today that it has raised a $1.5 They both settled that pharmacies in Ghana needed to imbibe the world of medical testing.

Testing 257

Testing Healthcare System Network 257

TechCrunch

OCTOBER 14, 2021

We learned through clinical testing that capsules were one of the worst ways to deliver enzymes,” Liu said. I was very impressed by their focus on empiric validation, with plans for both in vitro model system testing, and as it’s generally regarded as a safe substance, rapid movement into clinical trials.”.

Biotech 227

Biotech Retail Groups Sustainability 227

TechCrunch

OCTOBER 24, 2022

Biotechs globally tend to have a long-term approach toward making money; in fact, such companies can still be worth billions with little to no revenue. A typical time frame for a new drug from creation to market entry can take up to a decade, so it made sense for 54gene to turn its lab capabilities to COVID testing as a new source of revenue.

Pharmaceuticals 261

Pharmaceuticals Company Biotech Research 261

TechCrunch

OCTOBER 18, 2022

Circular Genomics claims its new form of genetic testing can identify which medications will work for a patient in a fraction of that time. Hafez did say that circular RNA is rapidly expanding its presence in the biotech world. At first it may be an optional test not covered by insurance, with a cost around $1,000.

Games 210

Games Biotech Insurance Testing 210

Crunchbase News

MAY 6, 2024

A couple weeks ago, genetic testing provider 23andMe became the latest candidate to try out this route. Greenlight Biosciences , a biotech developing RNA products for health and agriculture, went public in early 2022 near the tail end of the SPAC boom, at an initial valuation around $1.2 It didn’t go well.

Biotech 104

Biotech Case Study Marketing Study 104

TechCrunch

APRIL 30, 2021

Later legislation required biotech and pharma companies to disclose monies paid to research partners. Think of how often, as a patient, providers aren’t aware of treatment or a test you’ve had elsewhere. Often you end up repeating a test because a provider doesn’t have a record of a test conducted elsewhere.

Healthcare 184

Healthcare Data Biotech Systems Review 184

TechCrunch

NOVEMBER 24, 2021

Tiamat Sciences is one biotech startup developing a more cost-effective biomolecule aimed at replacing more costly bioreactors. Tiamet would then be sending samples to customers for testing, which she believes will lead to some partnerships in 2022.

Biotech 227

Biotech Culture Social Games 227

TechCrunch

FEBRUARY 22, 2022

The world’s labs are under pressure to do more tests and process more materials, not just due to COVID but from the growing biotech and drug development sectors — and automation is the sure path forwards. Useful but it still relies entirely on human labor. and wider European markets.

Hardware 216

Hardware Biotech Technical Review Systems Review 216

TechCrunch

JUNE 1, 2021

The company’s system enters play when you have some exotic new compound you want to make in order to test it in real life, but don’t know how to make it. But they did say that like many companies in biotech they are doing what they can to support COVID-related therapies. Yoshua Bengio,” said Byrski.

Chemicals 246

Chemicals Artificial Inteligence Off-The-Shelf Biotech 246

TechCrunch

DECEMBER 3, 2020

Earlier this year, Everlywell launched an at-home COVID-19 test collection kit – the first of this type of test to receive an emergency authorization from the U.S. Earlier this year, Everlywell launched an at-home COVID-19 test collection kit – the first of this type of test to receive an emergency authorization from the U.S.

Virtualization 191

Virtualization Testing Healthcare Groups 191

TechCrunch

MARCH 5, 2021

At the end of last year, Rani Therapeutics raised $69 million in new funding to help further develop and test their platform. Next-gen skincare, silk without spiders and pollution for lunch: Meet the biotech startups pitching at IndieBio’s Demo Day. This will finance us for the next several years,” said Imran.

Biotech 252

Biotech Sustainability Technology Research 252

TechCrunch

JANUARY 12, 2021

The thesis is similar to the approach taken by companies like Senti Bio, another early-stage biotech company that raised $105 million earlier this month. Senti Bio raises $105 million for its new programmable biology platform and cancer therapies.

Biotech 237

Biotech Mobile Programming Engineering 237

TechCrunch

SEPTEMBER 7, 2021

a biotech company focused on developing “organ-on-a-chip” technology, closed an $82 million Series E round on Tuesday. The NIH has launched them into spac e to study the effects of spaceflight, and has been developing tissue chip testing and validation programs since 2010. Emulate Inc.,

Organization 185

Organization Biotech Systems Review Research 185

Crunchbase News

MAY 31, 2024

The Menlo Park, California-based biotech firm locked up a $5.5 The startup, born out of the Mayo Clinic , says it has developed a phenotyping test that gives insights into genetics to determine an individual’s cause of obesity. The test is already in use by obesity treatment providers in the U.S.

Artificial Inteligence 90

Artificial Inteligence Biotech Technical Review Internet 90

Crunchbase News

APRIL 17, 2024

Cancer-focused biotech Freenome , meanwhile, picked up $46 million less in its Series E compared to its Series D. For instance Bugcrowd , provider of a security testing platform, raised $102 million in its February Series E, which was more than triple the size of its Series D.

Biotech 86

Biotech Comparison Systems Review Survey 86

TechCrunch

DECEMBER 15, 2021

While Green declined to name specific clients, saying only that Phylagen is working closely with numerous big tech companies and commercial real estate companies, she said the business, cofounded by Harrison Dillon — he previously cofounded the industrial biotech firm Solazyme — is going like gangbusters heading into 2022.

Meeting 219

Meeting Biotech Real Estate Pharmaceuticals 219

Crunchbase News

MARCH 5, 2024

Freenome , $254M, biotech: This is just one of many big biotech raises this month. Blood-test developer Freenome raised a $254 million round led by drugmaker Roche. In general, the sector seems to be picking up after a slow start to the year with AI startups now raking in more than $3 billion for the current calendar year.

Games 75

Games Artificial Intelligence Artificial Inteligence Biotech 75

TechCrunch

APRIL 1, 2021

Achiko’s platform combines an app called Teman Sehat (“Health Buddy” in Indonesian) for payments and keeping test records, and proprietary low-cost testing kits using DNA aptamers, or synthetic strands of DNA, that are cheaper to manufacture than rapid or PCR tests. All these things are big pluses.

Biotech 167

Biotech Chemicals Testing Travel 167